Personalized Sequencing Assays for Cerebrospinal Fluid Liquid Biopsies in Children with Brain Tumors

Explore a cutting-edge presentation from the 2023 Cancer Genomics Consortium Annual Meeting that delves into the development and application of personalized sequencing assays for cerebrospinal fluid liquid biopsies in pediatric brain tumor patients. Learn about the latest advancements in this crucial field of cancer diagnostics and how these innovative techniques are revolutionizing the monitoring and treatment of brain tumors in children. Gain insights into the potential benefits and challenges of using liquid biopsies for non-invasive tumor detection and tracking in young patients.